| RS536522617 |
PRRC2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536534531 |
BLTP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536550976 |
PDE6D
|
Health Risk |
Pathogenic |
Joubert syndrome 22, Joubert syndrome 22 |
| RS536552621 |
CABP4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536554704 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile nephronophthisis, Nephronophthisis |
| RS536554790 |
TTN
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS536555705 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypersulfaturia, Nephrolithiasis susceptibility caused by SLC26A1 |
| RS536557651 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS536561101 |
ZNF408
|
Health Risk |
Conflicting classifications of pathogenicity |
Exudative vitreoretinopathy 6, Retinal dystrophy |
| RS536567108 |
COQ9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536570392 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS536571390 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS536578692 |
WDR62
|
Health Risk |
Likely pathogenic |
— |
| RS536586591 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Ehlers-Danlos syndrome |
| RS536588176 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS536593247 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS536596969 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Central core myopathy |
| RS536601676 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Brittle cornea syndrome 1, Cardiovascular phenotype |
| RS536602504 |
DNAH9
|
Health Risk |
Likely pathogenic |
Ciliary dyskinesia, primary |
| RS536607503 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS536611911 |
SHOC2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome-like disorder with loose anagen hair 1 |
| RS536615203 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS536622788 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal macular dystrophy type 2, Stargardt disease 4 |
| RS536634033 |
BRD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS536634385 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS536638039 |
HNF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cysts and diabetes syndrome, HNF1B-related disorder |
| RS536639583 |
HOXD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Synpolydactyly type 1, Brachydactyly type E1 |
| RS536644825 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS536645864 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536657086 |
AGRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS536657204 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Progressive familial heart block type IB |
| RS536661123 |
MEGF8
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS536673957 |
PPP1R13L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS536675517 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS536677256 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS536684123 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS536687809 |
PRKN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2 |
| RS536688211 |
AMH
|
Health Risk |
Conflicting classifications of pathogenicity |
AMH-related disorder, AMH-related disorder |
| RS536696110 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A3-related disorder |
| RS536706421 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial disease, Mitochondrial disease |
| RS536723496 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Mitchell syndrome |
| RS536725615 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Brittle cornea syndrome 1, Ehlers-Danlos syndrome |
| RS536728645 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS536728682 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS536742386 |
PDE6B
|
Health Risk |
Likely pathogenic |
Progressive cone dystrophy (without rod involvement), Rod-cone dystrophy |
| RS536744826 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS536746031 |
KCNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 1, Episodic ataxia type 1 |
| RS536746349 |
DGUOK
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 |
| RS536752090 |
LRRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS536758248 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS536758576 |
NDUFV1
|
Health Risk |
Pathogenic |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS536765190 |
RAX
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 3, RAX-related disorder |
| RS536767538 |
TMPRSS6
|
Health Risk |
Pathogenic |
— |
| RS536775508 |
MYSM1
|
Health Risk |
Pathogenic |
— |
| RS536786554 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS536794545 |
RNF216
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar ataxia-hypogonadism syndrome, Cerebellar ataxia-hypogonadism syndrome |
| RS536799104 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS536814318 |
HMBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS536823549 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS536826731 |
SLC27A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536847466 |
COQ9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536848431 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536853368 |
LARS2
|
Health Risk |
Likely pathogenic |
Perrault syndrome 4, Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome |
| RS536856848 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, CREBBP-related disorder |
| RS536864160 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS536869186 |
CACNA2D2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS536874549 |
GP1BB
|
Health Risk |
Pathogenic |
Thrombocytopenia, Bernard Soulier syndrome |
| RS536882233 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
HSPG2-related disorder, HSPG2-related disorder |
| RS536884553 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS536894832 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS536901634 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS536906561 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS536907995 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS536917758 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS536928726 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS536932803 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS536933380 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS536934629 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS536935095 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS536942937 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS536962908 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS536963649 |
HEPACAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts, Intellectual disability |
| RS537001725 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS537002656 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS537013895 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS537026414 |
CNTN2
|
Health Risk |
Pathogenic |
Epilepsy, familial adult myoclonic |
| RS537034419 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS537037014 |
EPB41
|
Health Risk |
Likely pathogenic |
EPB41-related disorder, EPB41-related disorder |
| RS537038850 |
ETFDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Glutaric acidemia type 2C |
| RS537043237 |
ALDH18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALDH18A1-related de Barsy syndrome, Abnormality of the nervous system |
| RS537046144 |
PEX16
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 8A (Zellweger), Peroxisome biogenesis disorder |
| RS537049075 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Susceptibility to mononeuropathy of the median nerve, mild |
| RS537057233 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopetrosis, Inborn genetic diseases |
| RS537060488 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS537063695 |
TTC19
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex III deficiency nuclear type 2, TTC19-related disorder |
| RS537066687 |
GFPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS537067344 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Cardiomyopathy |
| RS537071956 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS537072819 |
ACADS
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS537078152 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |